Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Review · June 25, 2024

Safety and Efficacy of Treatment With JAK Inhibitors in Patients With Scleroderma

Journal of Cutaneous Medicine and Surgery

 

Additional Info

Journal of Cutaneous Medicine and Surgery
Treatment Outcomes of Scleroderma With Janus Kinase Inhibitors: A Systematic Review
J Cutan Med Surg 2024 Jun 10;[EPub Ahead of Print], H Rijal, N Bouadi, V Piguet, I Mukovozov

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading